Robert S Kerrison1, Anna Robinson2, Hanna Skrobanski3,4, Ghalia Kayal5, Aradhna Kaushal5, Charlotte Ide-Walters6,7, Adam Todd2, Andrew Husband2, Shivali Lakhani8, Marsha Alter8, Christian von Wagner5, Lindsay MacDonald6. 1. School of Health Sciences, University of Surrey, Surrey, UK. R.Kerrison@Surrey.ac.uk. 2. School of Pharmacy, Newcastle University, Newcastle, UK. 3. School of Health Sciences, University of Surrey, Surrey, UK. 4. Acaster Lloyd Consulting Ltd, London, UK. 5. Department of Behavioural Science and Health, University College London, London, UK. 6. Cancer Intelligence Team, Cancer Research UK, London, UK. 7. School of Human Sciences, University of Greenwich, London, UK. 8. Middlesex Group of Local Pharmaceutical Committees, London, UK.
Correction to: BMC Health Serv Res 22, 268 (2022)https://doi.org/10.1186/s12913-022-07587-1Following publication of the original article [1], the authors identified an error in the author affiliations’ list.The author affiliations have been updated in this correction article and the original article [1] has been corrected.
Authors: Robert S Kerrison; Anna Robinson; Hanna Skrobanski; Ghalia Kayal; Aradhna Kaushal; Charlotte Ide-Walters; Adam Todd; Andrew Husband; Shivali Lakhani; Marsha Alter; Christian von Wagner; Lindsay MacDonald Journal: BMC Health Serv Res Date: 2022-02-28 Impact factor: 2.908